X

ASCPT Journal Family

ASCPT Journal Family

ASCPT is proud to publish three peer-reviewed scientific research journals, spanning clinical pharmacology, pharmacometrics and systems pharmacology, and translational science. Submit your own research today!
*You are not currently logged in, please log in to access members-only journal content.

Clinical Pharmacology & Therapeutics

CPT is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to advances in the nature, action, efficacy, and evaluation of therapeutics.

Submit to CPT

CPT: Pharmacometrics & Systems Pharmacology

PSP is a timely online-only, cross-disciplinary journal publishing advances in quantitative methods as applied in pharmacology, physiology, and therapeutics in humans.

Submit to PSP

Clinical and Translational Science

CTS highlights original research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease.

Submit to CTS

  • Additional Content
  • PSPost
  • Translational Bytes
  • ClinPharmPod
  • PSPod
  • Webinars
  • CPIC Guidelines
The ASCPT Journal Family provides more than cutting-edge scientific content. The latest research, news, and views from clinical pharmacology, pharmacometrics and systems pharmacology, and translational science are put into perspective in our blogs, podcasts, and webinars.
Upcoming Webinar
Title: Endogenous Biomarkers of Membrane Transporters and Model-Based Prediction of Clinical Drug-Drug Interactions
Date and Time: Monday, October 22, 2018 12:00 PM EDT
Speakers: Kenta Yoshida, PhD and Xinning Yang, PhD
Moderator: Ping Zhao, PhD
Description: CPT: Pharmacometrics & Systems Pharmacology (PSP) and the ASCPT Journal Family are pleased to present this webinar to update attendees on using modeling and simulation (M&S) methods to predict clinical drug-drug interactions (DDIs) based on endogenous biomarker data for membrane transporters.  Kenta Yoshida, PhD, Genentech, will review the recent PSP articles, Quantitative Prediction of OATP‐Mediated Drug‐Drug Interactions With Model‐Based Analysis of Endogenous Biomarker Kinetics by Yoshida, et al. and PBPK Modeling of Coproporphyrin I as an Endogenous Biomarker for Drug Interactions Involving Inhibition of Hepatic OATP1B1 and OATP1B3 by Yoshikado, et al. Following the presentation, Dr. Yoshida will be joined by Xinning Yang, PhD, US Food and Drug Administration, for a discussion on regulatory perspectives of using biomarker data to guide DDI strategy in general, and the readiness of updating regulatory recommendations on using M&S and biomarker data to predict transporter-based DDIs.  
Registration: https://attendee.gotowebinar.com/register/7758762468973599747 

Past Webinars
ASCPT Members can access all webinar recordings through the ASCPT Webinar Library
Photo Gallery
Recent News
Contact Us